1. Home
  2. PRQR vs RAC Comparison

PRQR vs RAC Comparison

Compare PRQR & RAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

N/A

Current Price

$1.84

Market Cap

262.5M

Sector

Health Care

ML Signal

N/A

RAC

Rithm Acquisition Corp. Class A Ordinary Shares

HOLD

Current Price

$10.58

Market Cap

307.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRQR
RAC
Founded
2012
2024
Country
Netherlands
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
262.5M
307.3M
IPO Year
2014
2025

Fundamental Metrics

Financial Performance
Metric
PRQR
RAC
Price
$1.84
$10.58
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$7.25
N/A
AVG Volume (30 Days)
887.4K
28.2K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.92
N/A
P/E Ratio
N/A
$35.57
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$10.19
52 Week High
$3.10
$10.60

Technical Indicators

Market Signals
Indicator
PRQR
RAC
Relative Strength Index (RSI) 37.87 65.91
Support Level $1.37 $10.29
Resistance Level $1.99 N/A
Average True Range (ATR) 0.11 0.01
MACD -0.06 0.00
Stochastic Oscillator 7.92 71.47

Price Performance

Historical Comparison
PRQR
RAC

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

About RAC Rithm Acquisition Corp. Class A Ordinary Shares

Rithm Acquisition Corp is a blank check company.

Share on Social Networks: